Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgery
NCT06917859Phase 1Recruiting
- Sponsor
- Ain Shams University
- Start
- Feb 2025
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of methylprednisolone in acute kidney injury (AKI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of occurrence of postoperative acute kidney injury at 7 days. Started Feb 2025; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06917859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06917859.